Showing results (1371-1380 of 1,519) with videos related to

Sort By:
Pageof 152
Leukemia Research|May 31, 2016
Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: Comparable to de novo acute myeloid leukemiaFei-Fei Tang, Xiao-Jun Huang, Xiao-Hui Zhang, et al.
Blood Advances|January 15, 2025
α-Actinin-1 deficiency in megakaryocytes causes low platelet count, platelet dysfunction, and mitochondrial impairmentXiangjie Lin, Hanchen Gao, Min Xin, et al.
Frontiers in Oncology|October 5, 2020
Expert Consensus for Treating Cancer Patients During the Pandemic of SARS-CoV-2Shuang Dong, Chenggang Luo, Xuebo Hu, et al.
Bone Marrow Transplantation|March 24, 2019
Incidence and predictors of severe cardiotoxicity in patients with severe aplastic anaemia after haploidentical haematopoietic stem cell transplantationZheng-Li Xu, Lan-Ping Xu, Yuan-Yuan Zhang, et al.
Vaccine: X|June 13, 2020
Unbiased analysis of peripheral blood mononuclear cells reveals CD4 T cell response to RSV matrix proteinJuilee Thakar, Yu Qian, Lauren Benoodt, et al.
Theranostics|February 12, 2020
Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCCPengzhou Kong, Enwei Xu, Yanghui Bi, et al.
Environmental Science & Technology|October 24, 2024
Seed Priming with Dynamically Transformed Selenium Nanoparticles to Enhance Salt Tolerance in RiceRong-Xiang Xing, Xiao-Dong Sun, Yue Wang, et al.
Medcomm|January 19, 2026
Low Dose of IL-2 Application for Graft-Versus-Host Disease Prophylaxis Following Haploidentical Stem Cell TransplantationZheng-Li Xu, Meng Lv, Xing-Xing Yu, et al.
Heliyon|September 25, 2024
Efficacy and safety of compound porcine cerebroside and ganglioside injection (CPCGI) versus piracetam on cognition and functional outcomes for adults with traumatic brain injury: A study protocol for randomized controlled trialTao Liu, Yunhu Yu, Liang Mi, et al.
Haematologica|October 12, 2023
Targeting T<sub>FH</sub> cells is a novel approach for donor-specific antibody desensitization of allograft candidates: an <i>in vitro</i> and <i>in vivo</i> studyNing Ma, Wei-Bing Wu, Xiang-Yu Zhao, et al.
Pageof 152